Renovos News

Injectable Renovite gel for localised tissue regeneration

Renovos wins Innovate UK’s Biomedical Catalyst funding!

February 23, 2022 / Renovos Media Team / Company News

Renovos has been awarded a £692,472 Biomedical Catalyst grant from Innovate UK, the UK’s innovation agency*. Innovate UK funds businesses to accelerate promising innovations towards commercially successful products, in specific

How Renovite nanoclays open up new opportunities in regenerative medicine

June 1, 2021 / Renovos Media Team / Company News

For anyone pioneering a new technology in regenerative medicine, it’s not long before you are asked what it is that sets your tech apart from the rapidly growing number of

Nanoclays and regenerative medicine: a journey towards the clinic

April 8, 2021 / Renovos Media Team / Company News

What role could clay play in the biomedical field and why is Renovos Biologics focussing on this industrial-type material for cutting edge regenerative medicine technologies? It is an interesting question,

Chemistry? Clays? Isn’t this a biologics company?

January 26, 2021 / Renovos Media Team / Company News

I’m a chemist working on clay for a biologics company. That may well sound like a juxtaposition. Add to that the fact that the biological application isn’t to do with

Renovos wins Innovate UK SMART grant

November 1, 2020 / Renovos Media Team / Company News

We are excited to announce that we have launched another project funded by Innovate UK! Renovos won funding via the highly competitive SMART competition run by Innovate UK, the UK’s

Renovos Biologics has appointed Patrick O’Donnell as Advisor to the Board

October 20, 2020 / Renovos Media Team / Company News

Patrick O’Donnell Previously a General Manager and Executive Vice-President of North America for BoneSupport A.B., CEO at Proteothera, Inc, Histogenics Corporation, Prochon-BioTech, and in commercial roles of escalating management responsibility

Nature Communications magazine featuring Renovos

Three new nanoclay publications out this year!

May 18, 2020 / Renovos Media Team / Company News

Key read for nanoclays in drug delivery – group’s new publication on nanoclay in Nature Communications! The paper, which can be found here, reports on the use of bisphosphonate interactions

Renovos and its Nanoclay technology reviewed by Orthoworld

March 20, 2020 / Renovos Media Team / Company News

Renovos and our advanced nanoclay biomaterial, Renovite®, has been featured in Orthoworld. The article, “Renovos to Develop Next-Gen Technology to “Tame” BMP-2 Diffusion”, outlines key issues that novel regenerative medicine

Renovos receives investment for nanoclay innovation from leading medical research charity Orthopaedic Research UK

February 3, 2020 / Renovos Media Team / Company News

Renovos has recently been awarded one of the very first charity investments in the UK. In a progressive move to find new ways to support people living with painful and

Our nanoclay has been featured on the cover of Orthoworld’s Bonezone!

December 20, 2019 / Renovos Media Team / Company News

The synthetic nanoclay gel scaffold effectively localises new bone formation (in red). It offers injectable delivery and retention of biologics, released only to in-growing cells for efficacy at ultra-low doses

Innovation Challenge Finalist at RESI Boston

October 11, 2019 / Renovos Media Team / Company News

The Redefining Early Stage Investments (RESI) Conference took place on Wednesday 11th September 2019 in Boston. The organisers at Life Science Nation (LSN) invite all global early-stage companies across

Renovos and Caltag at BRS/BORS Cardiff

September 5, 2019 / Renovos Media Team / Company News

Working with Caltag Medsystems at BRS/BORS 2019 to spead the word about Renovos and our mesenchymal stem cell products. Together with Hannah from Caltag Medsystems, Renovos participated in Bone Research

Renovos Biologics has appointed Simon Sinclair as non-executive director

April 18, 2019 / Renovos Media Team / Company News

Simon Sinclair Previously in clinical trials at Merck & Co. Inc. and in medical affairs at DePuy Synthes and Johnson & Johnson, Simon is now working in safety and vigilance

Impact White Paper

February 27, 2019 / Renovos Media Team / Company News

Harnessing clay for regenerative medicine An Impact white paper Jon Dawson and Richard Oreffo have written a white paper on the nanoclay platform for Impact. In particular they share

Renovos at The Royal Society of Chemistry

October 15, 2018 / Renovos Media Team / Company News

On the 15th October Renovos took part in a Royal Society of Chemistry event called Chemistry means Business. This event is the flagship event for companies which are around Renovos’ size

Renovos Launches Innovate UK Grant!

March 8, 2018 / Renovos Media Team / Company News

We are excited to announce that we have launched our grant from Innovate UK! Innovate UK is a public body that aims to support the development of science and technology

Exhibiting technologies at Venturefest Oxford

June 22, 2017 / Renovos Media Team / Company News

Renovos showcased at VentureFest Oxford - a gateway for entrepreneurs and innovators to connect with investors and advisors

Showcasing our products to business giants at Canary Wharf

May 27, 2017 / Renovos Media Team / Company News

Renovos showcased to big name corporates including EDF Energy, Rolls-Royce and Samsung in Canary Wharf, London on 25 May 2017

Pitching for investment and showcasing technologies at Venturefest South

March 10, 2017 / Renovos Media Team / Company News

We showcased our innovative clay-gel technology used to aid the healing process of bone fractures at Venturefest South

Cocoon Networks China-UK Hi! Technology Festival

December 8, 2016 / Renovos Media Team / Company News

Renovos took part in the China-UK Hi! Technology Festival in November 2016 organised by Cocoon Networks an international startup ecosystem based in London

Renovos at Accelerating Growth with attendees

SetSquared Accelerating Growth Showcase

November 20, 2016 / Renovos Media Team / Company News

Renovos was among the high-growth tech entrepreneurs pitching for a share of more than £25m backing at the Showcase in London in November 2016.